Several aspects of phagocyte biology have been studied using neutrophils (PMN) and monocytes. Investigation of the subcellular location of fmet-leu-phe, C3bi as well as for cytochrome b suggests these constituents are packaged in a common compartment similar to specific granules. In related studies a series of monoclonal antibodies against the inside of the neutrophil plasma membrane have been developed with the goal of identifying specific secretory granule attachment sites. Studies in exudate PMN have revealed greater than five-fold more fmet-leu-phe receptors than blood PMN, presumably related to receptors mobilized from the intracellular pool. In studies extending our earlier work on neutrophil heterogeneity a monoclonal antibody, 31D8, that binds to a subpopulation of PMN was studied in chronic myelogenous leukemia (CML). The data indicate there are two groups of CML patients; those with 31D8 bright or dull PMN. It is not clear whether or not the CML heterogeneity reflects differences in clonal proliferation. Unexpectedly absence of the 31D8 antigen appeared predictive of progression of CML to the accelerated phase. Studies of IgE turnover in the Hyperimmunoglobulin E-recurrent infection (Job's) syndrome have revealed decreased clearance of IgE in subjects with elevated IgE. This has implications for numerous diseases in which IgE is elevated. In other studies gamma interferon was shown to be a chemoattractant for PMN and monocytes and this may relate to gamma interferon's ability to induce macrophage giant cell formation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000155-10
Application #
4688371
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
10
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Niaid Extramural Activities
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Sobhanie, Mahdee; Matsuoka, Yumiko; Jegaskanda, Sinthujan et al. (2016) Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9). J Infect Dis 213:922-9
O'Donnell, Christopher D; Vogel, Leatrice; Matsuoka, Yumiko et al. (2014) The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccines. J Virol 88:12374-84
Baz, Mariana; Luke, Catherine J; Cheng, Xing et al. (2013) H5N1 vaccines in humans. Virus Res 178:78-98
Talaat, Kawsar R; Karron, Ruth A; Luke, Catherine J et al. (2011) An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults. Vaccine 29:3144-8
Kuhns, Douglas B; Alvord, W Gregory; Heller, Theo et al. (2010) Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med 363:2600-10
Talaat, Kawsar R; Karron, Ruth A; Callahan, Karen A et al. (2009) A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults. Vaccine 27:3744-53
Karron, Ruth A; Talaat, Kawsar; Luke, Catherine et al. (2009) Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults. Vaccine 27:4953-60
Suguitan Jr, Amorsolo L; Marino, Michael P; Desai, Purvi D et al. (2009) The influence of the multi-basic cleavage site of the H5 hemagglutinin on the attenuation, immunogenicity and efficacy of a live attenuated influenza A H5N1 cold-adapted vaccine virus. Virology 395:280-8
Zarember, Kol A; Cruz, Anna R; Huang, Chiung-Yu et al. (2009) Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against Aspergillus fumigatus. Antimicrob Agents Chemother 53:2654-6
De Ravin, Suk See; Shum, Elaine; Zarember, Kol A et al. (2008) Short stature in partially corrected X-linked severe combined immunodeficiency--suboptimal response to growth hormone. J Pediatr Endocrinol Metab 21:1057-63

Showing the most recent 10 out of 30 publications